Stable coronary artery disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Diagnostic Criteria: (1) Meets the diagnostic criteria for SCAD as outlined in the "Guidelines for the Diagnosis and Treatment of Stable Coronary Heart Disease" (2018) issued by the Cardiovascular Disease Branch of the Chinese Medical Association and the Editorial Board of the "Chinese Journal of Cardiology", as well as the "Guidelines for Primary Care Diagnosis and Treatment of Stable Coronary Heart Disease" (2020), including chronic stable exertional angina, the stable phase following acute coronary syndrome, asymptomatic ischemic heart disease, spasm-induced angina, and microvascular angina. History of myocardial infarction; coronary angiography confirming coronary artery stenosis >= 50%; non-invasive testing confirming coronary artery stenosis or evidence of myocardial ischemia. (2) Meets the diagnostic criteria for XIONG BI in Traditional Chinese Medicine. Diagnosis is based on a holistic differential diagnosis through the integrated application of the Four Examinations (inspection, auscultation, inquiry, and palpation). Based on primary symptoms (stabbing pain in the chest and flanks, fixed and unmoving, triggered by emotional factors), secondary symptoms (flank distension, frequent sighing, and dark purple lips), and tongue and pulse findings (dark purple tongue or ecchymoses, and a string-like and rough pulse), the condition is diagnosed as Qi stagnation and blood stasis syndrome. 2. Inclusion Criteria: (1) Age 50-80 years. (2) New York Heart Association (NYHA) functional class I or II. (3) Alert and focused, able to cooperate fully with all assessments and exercise training. (4) Willing to undergo treatment and sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients with uncontrolled unstable angina pectoris and severe arrhythmias; 2. Patients with uncontrolled and unstable hypertension; 3. Patients with severe cardiopulmonary insufficiency; 4. Patients with severe hepatic or renal diseases, malignant tumors, or acute infections; 5. Patients with concomitant motor dysfunction; 6. Patients with impaired consciousness who are unable to follow instructions or complete assessments and motor tasks; 7. Patients with severe anxiety and depressive symptoms caused by illness who are unable to cooperate; 8. Patients who withdrew from the study midway due to various reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| cardiac function;brain-derived neurotrophic factor;cardio-pulmonary function;heart rate variability; | — |
Countries
China
Contacts
Affiliated Hospital of Shandong University of Traditional Chinese Medicine